English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Defining body composition has always been challenging and a wide range of methods have been developed. Amongthem, computed tomography (CT) is on the rise as a strong correlation exists between tissues at abdominal levels and the whole body composition[1]. Formulas link muscle and fat area at the third lumbar level (L3) with total fat mass and fat-free mass (mostly muscles and organs) in kilograms[2]. An index of muscularity (IMS) was also computed by dividing the muscle area at L3 by the height squared (cm2/m2). This technique is mainly used in cancer studies. Imaging methods such as CT and magnetic resonance imaging (MRI) have shown that muscle and fat behave differently in cancer-related weight loss, part of the well-known cancer cachexia. Here, we confirmed that classic tools such as body weight, body mass index (BMI) and body surface area (BSA) are not sufficient for evaluating body composition in a cohort of 152 colorectal and lung cancer patients. For instance, in normal BMI range (18.5–24.9kg/m2) and overweight/obese category (>25kg/m2), respectively 53% and 30% were sarcopenic. Recent studies have shown that the role of muscle mass and quality is critical. Sarcopenia, used here as a synonym of low muscularity, is strongly linked to prognosis and dose-limiting toxicities of chemotherapy. That is consistent with different types of cancer and therapy[3]. Further more, these associations between CT-defined body composition and cancer out comes were validated in more than 50 studies, including thousands of patients all over the world. CT-based method takes advantage of images that are acquired in standard care for staging or follow-up of cancer patients. It is a prognosis tool that could also improve scaling of treatments. The field is promising and it is highly realistic for routine use in any hospital that has a computer and a CT.

Abdominal Fat and Muscle Measurement on Routine CT: Is It Useful?